Terazosin Hydrochloride
- Product NDC
- 21695-812
- 11-digit product format
- 216950812
- Labeler code
- 21695
- Product ID
- 21695-812_a00604ff-041d-4ad4-a3bb-d0911bf0727e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2009-07-01
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21695-812-90 | Terazosin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21695-812 | TERAZOSIN HYDROCHLORIDE CAPSULE [REBEL DISTRIBUTORS CORP] | 1 | Legacy NDC, 1 package rows | 20110121_a00604ff-041d-4ad4-a3bb-d0911bf0727e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 21695-812-90 | 21695081290 | 90 in 1 BOTTLE | Historical |